Vickie l. Capps

Vickie l. Capps, listed as senior executive, has filed trades across 5 companies (mainly through SEC (Form 4)), most often in Amedisys Inc, Janux Therapeutics, Inc. and Orthofix Medical Inc. In total, 17 filings cover trades dated from 8 June 2021 to 11 June 2026.

Market trades split into 1 purchase (€27k) and 1 sale (€4,189). The net balance comes to €23k on the buying side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 11 share grants. Since January 2026: 1 purchase and no sales on the market.

On 12 June 2026 came the latest disclosure, a share grant in Orthofix Medical Inc. The last purchase on record was published on 10 March 2026, which is 222 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.